Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Dermatologic 1Breast 1

Conditions

Vaping 1Uterine Cervical Dysplasia 1Smoking Cessation 1Cutaneous Squamous Cell Carcinoma 1Breast Neoplasms 1Agnosia 1

Interventions

Magnetic Resonance Spectroscopy 271Specimen Handling 266pembrolizumab 233Cyclophosphamide 219Radiotherapy 208Nivolumab 169Cisplatin 165Biopsy 152Carboplatin 145Radiosurgery 131fludarabine 125Blood Specimen Collection 120Gemcitabine 113Paclitaxel 109Surveys and Questionnaires 108Standard of Care 106venetoclax 97Dexamethasone 95Bevacizumab 93Radiation 87Rituximab 83Capecitabine 81Cytarabine 80Oxaliplatin 77Drug Therapy 76Doxorubicin 75Ipilimumab 74durvalumab 73fludarabine phosphate 70atezolizumab 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Transdermal Patch × 90 days × Clear all
NCT05377905 2026-04-09

cSCC

University of Pittsburgh

Phase 1/2 Recruiting
48 enrolled
Dermatologic

Cutaneous Squamous Cell Carcinoma

NCT01989923 2026-04-07

Smoking Cessation in Women With Gynecological Conditions

University of Oklahoma

Phase NA Completed
31 enrolled
Gynecologic

Vaping, Uterine Cervical Dysplasia, Smoking Cessation

NCT06807164 2026-03-27

SerCaBot

Centre Oscar Lambret

Phase 2 Recruiting
123 enrolled
Breast

Agnosia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡